Camlin Fine Sciences Limited (IN:CAMLINFINE)
:CAMLINFINE
Want to see IN:CAMLINFINE full AI Analyst Report?
CAMLINFINE Stock Chart & Stats
₹144.30
-₹3.37(-2.50%)
At close: 4:00 PM EST
₹144.30
-₹3.37(-2.50%)
Day’s Range― - ―
52-Week Range₹96.30 - ₹334.70
Previous CloseN/A
Volume719.11K
Average Volume (3M)39.05K
Market Cap
₹24.39B
Enterprise Value₹29.44B
Total Cash (Recent Filing)₹1.63B
Total Debt (Recent Filing)₹6.72B
Price to Earnings (P/E)―
Beta0.67
Next Earnings
May 22, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding192,091,610
10 Day Avg. Volume26,894
30 Day Avg. Volume39,045
Financial Highlights & Ratios
PEG Ratio-0.48
Price to Book (P/B)3.33
Price to Sales (P/S)1.80
P/FCF Ratio-190.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹170.00Price Target Upside17.81% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)10.9
Revenue Forecast (FY)₹21.16B
Bulls Say, Bears Say
Bulls Say
B2B Specialty-chemicals Revenue ModelCamlin’s B2B model supplies specialty ingredients and additives to food, beverage and industrial customers. This creates recurring, contract-driven demand tied to manufacturing needs, supporting more predictable revenue streams and durable customer relationships over months.
Diversified Ingredient Portfolio Across Food And Industrial UsesA product mix spanning antioxidants, shelf-life extension and aroma/performance chemicals serves multiple end-markets. That breadth reduces single-market dependency, enables cross-selling, and benefits from structural demand for preservation and sensory solutions in food and industrial supply chains.
Relatively Strong Equity Ratio With Moderate LeverageBalance-sheet metrics show moderate leverage but substantial equity coverage, indicating asset backing for obligations. A 44.5% equity ratio provides financial stability to absorb cyclical shocks, supporting operational continuity while management works to restore profitability.
Bears Say
Sustained Negative ProfitabilityThe company has posted negative net income for consecutive years and a -8.34% net margin in the latest period. Persistent losses erode retained earnings, constrain reinvestment, hurt return metrics, and increase reliance on external financing or material margin improvement to sustain operations.
Deteriorating Cash Generation And Negative Free Cash FlowOperating cash flow declines and negative free cash flow limit the company’s ability to fund capex, working capital, and debt service from internal sources. This amplifies liquidity risk, reduces strategic flexibility and raises the urgency of restoring positive cash conversion over the medium term.
Modest Revenue Growth Insufficient To Offset LossesTop-line expansion is modest (~4.5% reported), which provides limited operating leverage to absorb fixed costs and reverse losses. Without stronger, sustained revenue acceleration or margin recovery, profitability restoration will remain challenging and dependent on structural demand gains or cost reductions.
Camlin Fine Sciences Limited News
CAMLINFINE FAQ
What was Camlin Fine Sciences Limited’s price range in the past 12 months?
Camlin Fine Sciences Limited lowest stock price was ₹96.30 and its highest was ₹334.70 in the past 12 months.
What is Camlin Fine Sciences Limited’s market cap?
Camlin Fine Sciences Limited’s market cap is ₹24.39B.
When is Camlin Fine Sciences Limited’s upcoming earnings report date?
Camlin Fine Sciences Limited’s upcoming earnings report date is May 22, 2026 which is in 21 days.
How were Camlin Fine Sciences Limited’s earnings last quarter?
Camlin Fine Sciences Limited released its earnings results on Feb 13, 2026. The company reported -₹0.25 earnings per share for the quarter, missing the consensus estimate of ₹0.6 by -₹0.85.
Is Camlin Fine Sciences Limited overvalued?
According to Wall Street analysts Camlin Fine Sciences Limited’s price is currently Undervalued.
Does Camlin Fine Sciences Limited pay dividends?
Camlin Fine Sciences Limited pays a Annually dividend of ₹0.45 which represents an annual dividend yield of N/A. See more information on Camlin Fine Sciences Limited dividends here
What is Camlin Fine Sciences Limited’s EPS estimate?
Camlin Fine Sciences Limited’s EPS estimate is 0.1.
How many shares outstanding does Camlin Fine Sciences Limited have?
Camlin Fine Sciences Limited has 192,091,610 shares outstanding.
What happened to Camlin Fine Sciences Limited’s price movement after its last earnings report?
Camlin Fine Sciences Limited reported an EPS of -₹0.25 in its last earnings report, missing expectations of ₹0.6. Following the earnings report the stock price went down -2.633%.
Which hedge fund is a major shareholder of Camlin Fine Sciences Limited?
Currently, no hedge funds are holding shares in IN:CAMLINFINE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as natural antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; and nutraceutical products from fermentation and plant extraction sources. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, HQEE, etc. The company also exports its products. Its products are used in food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemical, agrochemical, pharmaceutical, polymers, dyes and pigment, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplement industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
CAMLINFINE Stock 12 Month Forecast
Average Price Target
₹170.00
▲(17.81% Upside)
Technical Analysis
Advanced Enzyme Technologies Ltd
―
Balaji Amines Limited
―
Neogen Chemicals Ltd.
―
Premier Explosives Limited
―
Rossari Biotech Ltd
―